Chimeric lyssavirus glycoproteins with increased immunological potential - Wikidata - awgldk - TriplyDB

Chimeric lyssavirus glycoproteins with increased immunological potential

Chimeric lyssavirus glycoproteins with increased immunological potential

http://www.wikidata.org/entity/Q33639069

about

Diversity and epidemiology of Mokola virus Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans.The adaptation of a CTN-1 rabies virus strain to high-titered growth in chick embryo cells for vaccine development.Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity An electrochemiluminescence assay for analysis of rabies virus glycoprotein content in rabies vaccines Lagos bat virus in Kenya.Evaluation of rabies biologics against Irkut virus isolated in China.Developments in rabies vaccines.Cross-protective and cross-reactive immune responses to recombinant vaccinia viruses expressing full-length lyssavirus glycoprotein genes.Pathogenicity and Immunogenicity of Recombinant Rabies Viruses Expressing the Lagos Bat Virus Matrix and Glycoprotein: Perspectives for a Pan-Lyssavirus Vaccine

P2860

Q21092275-89A37422-1B5F-4A32-A420-2B121596168C Q33514828-46C1E8FE-35B1-47F2-9BEE-30FA25445D33 Q33620685-A84CD7BE-B62B-4182-90CE-94A8962655EE Q33838289-9922F7C3-B40A-4D60-8FB0-831903B5D253 Q36057713-414A6313-95E3-4EC1-BC5D-4043E285EC8D Q36539910-D4E539F8-A2BA-4AEF-9D0A-333B20510E84 Q37470270-F99D211D-0266-440A-97D8-C3210CCF5D7C Q38031922-E8BD1523-F691-42B5-9ECB-46E3488D37D9 Q46214294-58105078-C125-4A26-B290-AA9C35B9943C Q56967894-F4320DE2-5C52-459B-9FB2-8491D6D05D07

P2860

Chimeric lyssavirus glycoproteins with increased immunological potential

http://www.wikidata.org/entity/Q33639069

description

1999 nî lūn-bûn

@nan

1999 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Chimeric lyssavirus glycoproteins with increased immunological potential

@ast

Chimeric lyssavirus glycoproteins with increased immunological potential

@en

type

label

Chimeric lyssavirus glycoproteins with increased immunological potential

@ast

Chimeric lyssavirus glycoproteins with increased immunological potential

@en

prefLabel

Chimeric lyssavirus glycoproteins with increased immunological potential

@ast

Chimeric lyssavirus glycoproteins with increased immunological potential

@en

P1433

Q33639069-93084233-B971-4BE8-B114-9B712689A209

P1476

Q33639069-2E7D99F7-444F-48D1-8B2C-56EF8FB530DA

P2093

Q33639069-10310914-9514-48E8-94C4-1481CDE183C6

Q33639069-1FE0B25D-FCCD-4D8C-9514-06DC58AF5710

Q33639069-77E0445C-B588-4F78-8EAD-E5CB022EB2E4

Q33639069-78EA6436-8D63-4E1B-8B68-9FC8E1E493C9

Q33639069-8F928ADA-B371-46E8-8E78-5BD0509C6598

Q33639069-9EEAEC46-8354-4589-ACAF-944D12D42F17

Q33639069-E3FE18C6-EF27-47A8-9B7D-C0ADE3422A2C

P2860

Q33639069-10BCC89E-62AE-45F5-A4E6-623DF9CEAE8D

Q33639069-1ACF462B-DC6F-4552-AB29-A223D39C4057

Q33639069-43CEF67A-928C-4927-A57D-E8A1DF110B45

Q33639069-48D9C4A4-7DC7-4240-9454-29F965DE3CCD

Q33639069-4AF6C0D2-BCB5-4381-85AB-E9A135104D82

Q33639069-55078378-BB36-4379-A999-3D8B867D8E23

Q33639069-6669F334-2926-4CF0-86DD-D19E3A0857AE

Q33639069-73424CA1-0332-4E36-A23E-0C4324FCA084

Q33639069-91F32978-591A-4D1C-BFE4-181C158B86B4

Q33639069-95636006-3C55-404B-A366-813CA0700950

P304

Q33639069-2C1335C2-27A0-48EA-98E5-AF8739662536

P31

Q33639069-B8661EED-B487-47FE-A6C5-72799E08B1BC

P433

Q33639069-616E3D3A-5439-4CE9-96DA-9B64A9344497

P478

Q33639069-3BD594B3-5FB8-4072-9C24-CA3835D5079D

P577

Q33639069-EAD2DFF6-CFE3-41E4-BCCE-9389B5426D86

P698

Q33639069-E3F79FF6-10E6-4B81-BD8D-D59B267E53CC

P921

Q33639069-42E7A1F2-0A96-4CB2-A8F6-97DBEE5A90C4

P932

Q33639069-BDDFE3BE-9C9A-4FFE-9786-7614ABEA3828

P1433

Journal of Virology

P1476

Chimeric lyssavirus glycoproteins with increased immunological potential

@en

P2093

Bahloul C

http://www.w3.org/2001/XMLSchema#string

Desmezieres E

http://www.w3.org/2001/XMLSchema#string

Drings A

http://www.w3.org/2001/XMLSchema#string

Jacob Y

http://www.w3.org/2001/XMLSchema#string

Jallet C

http://www.w3.org/2001/XMLSchema#string

Perrin P

http://www.w3.org/2001/XMLSchema#string

Tordo N

http://www.w3.org/2001/XMLSchema#string

P2860

Antigenicity of rabies virus glycoprotein

Biological function of the low-pH, fusion-inactive conformation of rabies virus glycoprotein (G): G is transported in a fusion-inactive state-like conformation

An avirulent mutant of rabies virus is unable to infect motoneurons in vivo and in vitro

Antigenic properties of rabies virus components.

Evolution of European bat lyssaviruses.

Cross-protection of mice against a global spectrum of rabies virus variants.

Rabies group-specific ribonucleoprotein antigen and a test system for grouping and typing of rhabdoviruses.

Reversible conformational changes and fusion activity of rabies virus glycoprotein.

Immunodominant epitopes defined by a yeast-expressed library of random fragments of the rabies virus glycoprotein map outside major antigenic sites.

Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine.

P304

225-233

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P577

1999-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9847325

http://www.w3.org/2001/XMLSchema#string

P921

P932

103826

http://www.w3.org/2001/XMLSchema#string